Vimecon Overview

  • Founded
  • 2005
  • Status
  • Out of Business
  • Employees
  • 7
  • Latest Deal Type
  • Out of Business

Vimecon General Information


Developer of catheter components and materials intended to treat cardiovascular diseases and cardiac arrhythmia. The company's components and materials are used for the treatment of atrial fibrillation and for research of genetic codes and stem cell, enabling healthcare institutions to avail advanced products and services for enhanced healthcare outcomes.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare
Primary Office
  • Kaiserstraße 100
  • 52134 Herzogenrath
  • Germany
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vimecon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Jan-2019 Completed Out of Business
3. Later Stage VC (Series C) 16-Dec-2014 Completed Generating Revenue
2. Later Stage VC 16-Jun-2011 Completed Generating Revenue
1. Early Stage VC 01-Jan-2008 Completed Startup
To view Vimecon’s complete valuation and funding history, request access »

Vimecon Executive Team (4)

Name Title Board Seat Contact Info
Kai Markus Founder, President & Chief Executive Officer
Carla Kikken-Jussen Managing Director & Vice President, Regulatory and Operations
Stephan Mohren Managing Director
Martin Hettkamp Technical Director
To view Vimecon’s complete executive team members history, request access »

Vimecon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial